FYI....AdvisorShares has an ETF that includes CRDL, they have held this position for over a year, last week they increased their number of shares by 17.91%, so obviously they continue to like the CRDL story!
Share weakness right now is due to the market conditions, it's needing a catalyst to generate further share price strength.
In December look for phase one approval by the FDA for AM, hopefully we might also see a NASDAQ listing.
If one or both occur they will be a very positive catalyst.
AdvisorShares Investments LLC reports 17.91% increase in ownership of CRDL / Cardiol Therapeutics Inc
November 12, 2020 - AdvisorShares Investments LLC has filed a 13F-HR form disclosing ownership of 287,106 shares of Cardiol Therapeutics Inc (CA:CRDL) with total holdings valued at $876,000 USD as of September 30, 2020. AdvisorShares Investments LLC had filed a previous 13F-HR on July 14, 2020 disclosing 243,504 shares of Cardiol Therapeutics Inc at a value of $577,000 USD. This represents a change in shares of 17.91 percent and a change in value of 51.82 percent during the quarter.